Janssen
Janssen reaches partial agreement over criminal investigation
August 10, 2011Sales and Marketing Janssen, Risperdal, US, US Justice Department, illegal
Janssen Pharmaceuticals has reached a partial agreement with the US government over a criminal investigation into the marketing of Risperdal. …
Janssen to collaborate with Jubilant on neuroscience targets
June 29, 2011Manufacturing and Production, Research and Development Janssen, Jubilant, neuroscience research
Janssen is to team up with Indian pharma services company Jubilant Life Sciences on neuroscience drug discovery. Jubilant Discovery Services …
GSK takes lead role in UK personalised medicine programme
May 20, 2011Research and Development AstraZeneca, GlaxoSmithKline, Ig Innovations, Janssen, Randox Laboratories, personalised medicine
The first cheque has been written for the government-backed Stratified Medicine Innovation Platform (SMIP), set up last year to pump …
Bayer-helmed oncology biomarker project launched
March 14, 2011Manufacturing and Production, Research and Development AstraZeneca, Bayer, Janssen, Max Planck Institute, Merck, OncoTrack, Pfizer, Roche, biomarkers, oncology
A project to develop the next generation of oncology biomarkers has been launched in Berlin. The pharma industry and European …
Janssen’s monthly antipsychotic approved in Europe
March 9, 2011Sales and Marketing Janssen, Xeplion, antipsychotic, injectible antipsychotic, paliperidone palmitate, schizophrenia
Janssen’s injectable antipsychotic Xeplion has been approved by the European Commission for the treatment of schizophrenia. There is no cure …
Janssen’s Invega wins schizoaffective approval in Europe
January 6, 2011Sales and Marketing Invega, Janssen, paliperidone ER, schizoaffective disorder, schizophrenia
Janssen’s Invega has become the first drug to be licensed in Europe to treat schizoaffective disorder. European regulators approved Invega …
Pharma manufacturing news in brief
December 21, 2010Manufacturing and Production Airgas, Anthera Pharmaceuticals, Avid Bioservices, Berlin Packaging, Continental Packaging Solutions, Inno Biologics, Janssen, Merck BioManufacturing Network, Shandong Yanggu Zhongshi Pharmaceutical, SurModics
Our round-up of manufacturing updates includes a European recall for J&J, new contract manufacturing awards and facility updates from around …
New hepatitis C drug offers cure for more patients
December 17, 2010Research and Development, Sales and Marketing HCV, Janssen, hepatitis C, liver disease, telaprevir
A new treatment from Janssen which could help cure many more patients with hepatitis C has been submitted in Europe. …
Digital Pharma: Facebook first from Janssen
October 8, 2010Medical Communications Digital Pharma blog, Facebook, Janssen, Twitter, ipad, iphone, youtube
Janssen UK has officially launched its new psoriasis disease awareness campaign, part of which includes the first pharma Facebook page …
Janssen leads the pack at PM Society Digital Awards
October 6, 2010Medical Communications Janssen, PM Society Digital Awards, disease awareness campaigns, pm society
Janssen was confirmed as one of the UK pharma industry’s most innovative pharma companies in the field of digital communications …
Caelyx rights to revert back to Janssen
September 30, 2010Sales and Marketing Caelyx, Janssen, Merck
Marketing rights for cancer treatment Caeylx outside the US will be returned to Janssen from Merck after a licensing deal …
Digital Pharma: Janssen unveils UK social media plans
September 23, 2010Medical Communications Digital Pharma blog, Facebook, Janssen, Twitter, psoriasis, social media, youtube
Janssen UK is to launch a wide-ranging social media campaign to raise awareness of the chronic skin condition psoriasis. The …
Digital Pharma: Byte-sized roundup
August 4, 2010Medical Communications Digital Pharma blog, Janssen, disease awareness campaigns, iphone, social media
This week’s roundup includes Janssen-Cilag’s YouTube success, FDA to boost social media work, Novartis iPhone profile, Pfizer on SlideShare and …
Digital Pharma: First app for psoriasis launched
June 30, 2010Medical Communications, Sales and Marketing Janssen, app, iphone, psoriasis
Janssen-Cilag UK has unveiled the first psoriasis iPhone app – a disease calculator for healthcare professionals treating the chronic skin condition. It …
Digital Pharma: The smokescreen of regulation
June 28, 2010Medical Communications, Sales and Marketing Janssen, social media
When framing a story for the media it is well known in the communications community that a successful piece must …
Latest content
Medtronic secures CE Mark for new cardiac pacing portfolio
Dermatology leader Doncker is new Onicor CEO
